Dr. Kaye is a Professor of Medicine in the Division of Infectious Diseases at the University of Michigan Medical School. Dr. Kaye's career has been devoted to prevention and management of healthcare-associated infections. 

In addition to serving quality improvement and administrative roles in infection prevention, antimicrobial stewardship and quality and patient safety, he has served on national and international clinical guidelines committees.

His research focuses on antimicrobial resistance, particularly among gram-negative bacilli; optimizing use of polymyxin antimicrobials; prevention of healthcare associated infections including multi-drug resistant organisms, device-associated infections and surgical site infections; and innovative approaches to antimicrobial stewardship. He is currently PI on 2 groundbreaking NIH-sponsored grants focusing on treatment of extremely-drug resistant Gram-negative bacilli. He also is dedicated to education and mentorship of trainees and students.

Dr. Kaye received his medical degree from the University of Pennsylvania and served his Internal Medicine residency and was an Infectious Diseases fellow at Beth Israel Deaconess Medical Center in Boston, MA. During fellowship, Dr. Kaye earned a Masters in Public Health from the Harvard School of Public Health. He is Board Certified in Infectious Diseases. Dr. Kaye has authored over 250 peer-reviewed articles and 17 book chapters. Dr. Kaye has been an international leader in infection prevention and antimicrobial stewardship.

Starting January 2018, please join SHEA in welcoming Dr. Kaye as the President of SHEA’s Board of Trustees.